My NCBI | Sign In
RSS Settings
  • Search: CUCHURAL GJ[au]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 25

    1.

    Multicenter study of in vitro susceptibility of the Bacteroides fragilis group, 1995 to 1996, with comparison of resistance trends from 1990 to 1996.

    Snydman DR, Jacobus NV, McDermott LA, Supran S, Cuchural GJ Jr, Finegold S, Harrell L, Hecht DW, Iannini P, Jenkins S, Pierson C, Rihs J, Gorbach SL.

    Antimicrob Agents Chemother. 1999 Oct;43(10):2417-22.PMID: 10508018 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Analysis of trends in antimicrobial resistance patterns among clinical isolates of Bacteroides fragilis group species from 1990 to 1994.

    Snydman DR, McDermott L, Cuchural GJ Jr, Hecht DW, Iannini PB, Harrell LJ, Jenkins SG, O'Keefe JP, Pierson CL, Rihs JD, Yu VL, Finegold SM, Gorbach SL.

    Clin Infect Dis. 1996 Dec;23 Suppl 1:S54-65.PMID: 8953108 [PubMed - indexed for MEDLINE]Related articles

    3.

    Correlation of various in vitro testing methods with clinical outcomes in patients with Bacteroides fragilis group infections treated with cefoxitin: a retrospective analysis.

    Snydman DR, Cuchural GJ Jr, McDermott L, Gill M.

    Antimicrob Agents Chemother. 1992 Mar;36(3):540-4.PMID: 1622162 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Antimicrobial susceptibility patterns of the Bacteroides fragilis group in the United States, 1989.

    Cuchural GJ Jr, Snydman DR, McDermott L, Iannini PB, Hill GB, Cleary TJ, O'Keefe JP, Pierson CL, Rihs JD, Finegold SM.

    Clin Ther. 1992 Jan-Feb;14(1):122-36.PMID: 1576621 [PubMed - indexed for MEDLINE]Related articles

    5.

    Newer beta-lactam agents and the Bacteroides fragilis group.

    Cuchural GJ Jr.

    Pharmacotherapy. 1991;11(2 ( Pt 2)):51S-55S. Review.PMID: 2041832 [PubMed - indexed for MEDLINE]Related articles

    6.

    The antimicrobial susceptibility patterns of the Bacteroides fragilis group in the United States, 1987.

    Cornick NA, Cuchural GJ Jr, Snydman DR, Jacobus NV, Iannini P, Hill G, Cleary T, O'Keefe JP, Pierson C, Finegold SM.

    J Antimicrob Chemother. 1990 Jun;25(6):1011-9.PMID: 2370237 [PubMed - indexed for MEDLINE]Related articles

    7.

    Comparative activities of newer beta-lactam agents against members of the Bacteroides fragilis group.

    Cuchural GJ Jr, Tally FP, Jacobus NV, Cleary T, Finegold SM, Hill G, Iannini P, O'Keefe JP, Pierson C.

    Antimicrob Agents Chemother. 1990 Mar;34(3):479-80.PMID: 2334161 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Imipenem resistance in Bacteroides distasonis mediated by a novel beta-lactamase.

    Hurlbut S, Cuchural GJ, Tally FP.

    Antimicrob Agents Chemother. 1990 Jan;34(1):117-20.PMID: 2327745 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    In-vitro susceptibility of the Bacteroides fragilis group and the inoculum effect of newer beta-lactam antibiotics on this group of organisms.

    Jacobus NV, Cuchural GJ Jr, Tally FP.

    J Antimicrob Chemother. 1989 Nov;24(5):675-82.PMID: 2599992 [PubMed - indexed for MEDLINE]Related articles

    10.

    Permeability to beta-lactams in Bacteroides fragilis.

    Cuchural GJ, Hurlbut S, Malamy MH, Tally FP.

    J Antimicrob Chemother. 1988 Dec;22(6):785-90.PMID: 3266619 [PubMed - indexed for MEDLINE]Related articles

    11.

    Antibiotic resistance in anaerobic bacteria.

    Tally FP, Cuchural GJ Jr.

    J Antimicrob Chemother. 1988 Jul;22 Suppl A:63-71.PMID: 3264832 [PubMed - indexed for MEDLINE]Related articles

    12.

    Susceptibility of the Bacteroides fragilis group in the United States: analysis by site of isolation.

    Cuchural GJ Jr, Tally FP, Jacobus NV, Aldridge K, Cleary T, Finegold SM, Hill G, Iannini P, O'Keefe JP, Pierson C, et al.

    Antimicrob Agents Chemother. 1988 May;32(5):717-22.PMID: 3395102 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Antimicrobial resistance in oral and colonic bacteroides.

    Crook DW, Cuchural GJ Jr, Jacobus NV, Tally FP.

    Scand J Infect Dis Suppl. 1988;57:55-64. Review.PMID: 3074473 [PubMed - indexed for MEDLINE]Related articles

    14.

    Clinical importance of cefoxitin-resistant Bacteroides fragilis isolates.

    Bieluch VM, Cuchural GJ, Snydman DR, Gorbach SL, Tally FP.

    Diagn Microbiol Infect Dis. 1987 Jun;7(2):119-26.PMID: 3652652 [PubMed - indexed for MEDLINE]Related articles

    15.

    Beta-lactamase-mediated imipenem resistance in Bacteroides fragilis.

    Cuchural GJ Jr, Malamy MH, Tally FP.

    Antimicrob Agents Chemother. 1986 Nov;30(5):645-8.PMID: 3492173 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Bacteroides fragilis: current susceptibilities, mechanisms of drug resistance, and principles of antimicrobial therapy.

    Cuchural GJ Jr, Tally FP.

    Drug Intell Clin Pharm. 1986 Jul-Aug;20(7-8):567-73.PMID: 3488895 [PubMed - indexed for MEDLINE]Related articles

    17.

    Transfer of beta-lactamase-associated cefoxitin resistance in Bacteroides fragilis.

    Cuchural GJ Jr, Tally FP, Storey JR, Malamy MH.

    Antimicrob Agents Chemother. 1986 May;29(5):918-20.PMID: 3488018 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Nationwide study of the susceptibility of the Bacteroides fragilis group in the United States.

    Tally FP, Cuchural GJ Jr, Jacobus NV, Gorbach SL, Aldridge K, Cleary T, Finegold SM, Hill G, Iannini P, O'Keefe JP, et al.

    Antimicrob Agents Chemother. 1985 Nov;28(5):675-7.PMID: 4091530 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Antimicrobial susceptibilities of 1,292 isolates of the Bacteroides fragilis group in the United States: comparison of 1981 with 1982.

    Cuchural GJ Jr, Tally FP, Jacobus NV, Gorbach SL, Aldridge K, Cleary T, Finegold SM, Hill G, Iannini P, O'Keefe JP, et al.

    Antimicrob Agents Chemother. 1984 Aug;26(2):145-8.PMID: 6486758 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Mechanisms of resistance and resistance transfer in anaerobic bacteria: factors influencing antimicrobial therapy.

    Tally FP, Cuchural GJ Jr, Malamy MH.

    Rev Infect Dis. 1984 Mar-Apr;6 Suppl 1:S260-9. Review.PMID: 6326243 [PubMed - indexed for MEDLINE]Related articles

    21.

    Clindamycin resistance in anaerobic bacteria.

    Tally FP, Cuchural GJ Jr, Bieluch VM, Jacobus NV, Malamy MH.

    Scand J Infect Dis Suppl. 1984;43:34-43.PMID: 6598519 [PubMed - indexed for MEDLINE]Related articles

    22.

    Kidney failure or cancer. Should immunosuppression be continued in a transplant patient with malignant melanoma?

    Cuchural GJ Jr, Levey AS, Pauker SG.

    Med Decis Making. 1984;4(1):82-107. No abstract available. PMID: 6374354 [PubMed - indexed for MEDLINE]Related articles

    23.

    Cefoxitin inactivation by Bacteroides fragilis.

    Cuchural GJ Jr, Tally FP, Jacobus NV, Marsh PK, Mayhew JW.

    Antimicrob Agents Chemother. 1983 Dec;24(6):936-40.PMID: 6660860 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    Susceptibility of the Bacteroides fragilis group in the United States in 1981.

    Tally FP, Cuchural GJ, Jacobus NV, Gorbach SL, Aldridge KE, Cleary TJ, Finegold SM, Hill GB, Iannini PB, McCloskey RV, O'Keefe JP, Pierson CL.

    Antimicrob Agents Chemother. 1983 Apr;23(4):536-40.PMID: 6859833 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    Growth rate patterns of solid tumors and their relation to responsiveness to therapy: an analytical review.

    Shackney SE, McCormack GW, Cuchural GJ Jr.

    Ann Intern Med. 1978 Jul;89(1):107-21.PMID: 666155 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    11 free full-text articles in PubMed Central

    Find related data

    Search details

    » See more...

    Recent activity